Canadians facing ovarian cancer deserve access to innovative precision treatments when they need them.

Ovarian Cancer Canada is urging our nation’s decision-makers to restart negotiations that make the innovative ovarian cancer treatment, ELAHERE, accessible to Canadians.

Canadians living with platinum-resistant ovarian cancer do not have the luxury of waiting for treatment until negotiations for ELAHERE end. They deserve access to this innovative treatment when they need it, not after systemic barriers decide they can have it.